Anti-body Drug Conjugates (ADC) Market Report

China Anti-body Drug Conjugates (ADC) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 20, 2023
  • PAGES：207
  • REPORT CODE：GMM1811667
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Anti-body Drug Conjugates (ADC) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Takeda Pharmaceutical Company Limited

    • Pfizer, Inc

    • Seagen, Inc

    • Astellas Pharma, Inc

    • ADC Therapeutics SA

    • Daiichi Sankyo Company Limited

    • Gilead Sciences, Inc

    • AstraZeneca

    • F Hoffmann-La Roche Ltd

    By Type:

    • Sulfo-SPDB

    • Others

    • VC

    • Hydrazone

    • VA

    By Application:

    • Lung Cancer

    • Blood Cancer

    • Other Applications

    • Skin Cancer

    • Breast Cancer

    • Ovary Cancer

    • Brain Tumor

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Anti-body Drug Conjugates (ADC) Market Overview 2018-2029

    • 1.1 China Anti-body Drug Conjugates (ADC) Industry Development Overview

    • 1.2 China Anti-body Drug Conjugates (ADC) Industry Development History

    • 1.3 China Anti-body Drug Conjugates (ADC) Industry Market Size (2018-2029)

    • 1.4 China Anti-body Drug Conjugates (ADC) Market Analysis by Type from Production Side

      • 1.4.1 China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Sulfo-SPDB (2018-2029)

      • 1.4.2 China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.3 China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of VC (2018-2029)

      • 1.4.4 China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Hydrazone (2018-2029)

      • 1.4.5 China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of VA (2018-2029)

    • 1.5 China Anti-body Drug Conjugates (ADC) Market Analysis by Application from Consumption End

      • 1.5.1 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.2 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

      • 1.5.3 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Other Applications (2018-2029)

      • 1.5.4 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Skin Cancer (2018-2029)

      • 1.5.5 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.6 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Ovary Cancer (2018-2029)

      • 1.5.7 China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

    • 1.6 China Anti-body Drug Conjugates (ADC) Market Analysis by Region

      • 1.6.1 North China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Anti-body Drug Conjugates (ADC) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Anti-body Drug Conjugates (ADC) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Anti-body Drug Conjugates (ADC) Market Status and Competition Analysis in 2023

      • 2.2.3 China Anti-body Drug Conjugates (ADC) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Anti-body Drug Conjugates (ADC) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Anti-body Drug Conjugates (ADC) Industry Development

    Chapter 3 Anti-body Drug Conjugates (ADC)Industry Chain Analysis

    • 3.1 Anti-body Drug Conjugates (ADC) Industry Chain

    • 3.2 Anti-body Drug Conjugates (ADC) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Anti-body Drug Conjugates (ADC) Market

    • 3.3 Anti-body Drug Conjugates (ADC) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Anti-body Drug Conjugates (ADC) Market

    Chapter 4 China Anti-body Drug Conjugates (ADC) Market, by Type

    • 4.1 China Anti-body Drug Conjugates (ADC) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Anti-body Drug Conjugates (ADC) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate, by Type

      • 4.5.1 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Sulfo-SPDB

      • 4.5.2 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Others

      • 4.5.3 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of VC

      • 4.5.4 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Hydrazone

      • 4.5.5 China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of VA

    Chapter 5 China Anti-body Drug Conjugates (ADC) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Anti-body Drug Conjugates (ADC) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate, by Application

      • 5.5.1 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Lung Cancer

      • 5.5.2 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Blood Cancer

      • 5.5.3 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Other Applications

      • 5.5.4 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Skin Cancer

      • 5.5.5 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Breast Cancer

      • 5.5.6 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Ovary Cancer

      • 5.5.7 China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Brain Tumor

    Chapter 6 China Anti-body Drug Conjugates (ADC) Market, by Region

    • 6.1 China Anti-body Drug Conjugates (ADC) Production Volume and Production Value, by Region

    • 6.2 China Anti-body Drug Conjugates (ADC) Sales Volume and Sales Value, by Region

    Chapter 7 North China Anti-body Drug Conjugates (ADC) Market Analysis

    • 7.1 North China Anti-body Drug Conjugates (ADC) Market, by Type

    • 7.2 North China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 8 Central China Anti-body Drug Conjugates (ADC) Market Analysis

    • 8.1 Central China Anti-body Drug Conjugates (ADC) Market, by Type

    • 8.2 Central China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 9 South China Anti-body Drug Conjugates (ADC) Market Analysis

    • 9.1 South China Anti-body Drug Conjugates (ADC) Market, by Type

    • 9.2 South China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 10 East China Anti-body Drug Conjugates (ADC) Market Analysis

    • 10.1 East China Anti-body Drug Conjugates (ADC) Market, by Type

    • 10.2 East China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 11 Northeast China Anti-body Drug Conjugates (ADC) Market Analysis

    • 11.1 Northeast China Anti-body Drug Conjugates (ADC) Market, by Type

    • 11.2 Northeast China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 12 Southwest China Anti-body Drug Conjugates (ADC) Market Analysis

    • 12.1 Southwest China Anti-body Drug Conjugates (ADC) Market, by Type

    • 12.2 Southwest China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 13 Northwest China Anti-body Drug Conjugates (ADC) Market Analysis

    • 13.1 Northwest China Anti-body Drug Conjugates (ADC) Market, by Type

    • 13.2 Northwest China Anti-body Drug Conjugates (ADC) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Takeda Pharmaceutical Company Limited

        • 14.1.1 Takeda Pharmaceutical Company Limited Company Profile

        • 14.1.2 Takeda Pharmaceutical Company Limited Anti-body Drug Conjugates (ADC) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer, Inc

        • 14.2.1 Pfizer, Inc Company Profile

        • 14.2.2 Pfizer, Inc Anti-body Drug Conjugates (ADC) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Seagen, Inc

        • 14.3.1 Seagen, Inc Company Profile

        • 14.3.2 Seagen, Inc Anti-body Drug Conjugates (ADC) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Astellas Pharma, Inc

        • 14.4.1 Astellas Pharma, Inc Company Profile

        • 14.4.2 Astellas Pharma, Inc Anti-body Drug Conjugates (ADC) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 ADC Therapeutics SA

        • 14.5.1 ADC Therapeutics SA Company Profile

        • 14.5.2 ADC Therapeutics SA Anti-body Drug Conjugates (ADC) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Daiichi Sankyo Company Limited

        • 14.6.1 Daiichi Sankyo Company Limited Company Profile

        • 14.6.2 Daiichi Sankyo Company Limited Anti-body Drug Conjugates (ADC) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Gilead Sciences, Inc

        • 14.7.1 Gilead Sciences, Inc Company Profile

        • 14.7.2 Gilead Sciences, Inc Anti-body Drug Conjugates (ADC) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AstraZeneca

        • 14.8.1 AstraZeneca Company Profile

        • 14.8.2 AstraZeneca Anti-body Drug Conjugates (ADC) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 F Hoffmann-La Roche Ltd

        • 14.9.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.9.2 F Hoffmann-La Roche Ltd Anti-body Drug Conjugates (ADC) Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Anti-body Drug Conjugates (ADC) Industry Research Conclusions

    • 15.2 Anti-body Drug Conjugates (ADC) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Anti-body Drug Conjugates (ADC) Industry Market Size (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Sulfo-SPDB (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of VC (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of Hydrazone (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume, Production Value and Growth Rate of VA (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Other Applications (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Skin Cancer (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Ovary Cancer (2018-2029)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume, Sales Value and Growth Rate of Brain Tumor (2018-2029)

    • Figure North China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure Central China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure South China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure East China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate from 2018-2029

    • Figure Anti-body Drug Conjugates (ADC) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Anti-body Drug Conjugates (ADC) Market Share by Type in 2018

    • Figure China Anti-body Drug Conjugates (ADC) Market Share by Type in 2023

    • Figure China Anti-body Drug Conjugates (ADC) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Sulfo-SPDB (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of VC (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of Hydrazone (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume and Growth Rate of VA (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Share by Application in 2018

    • Figure China Anti-body Drug Conjugates (ADC) Market Share by Application in 2023

    • Figure China Anti-body Drug Conjugates (ADC) Total Market Size and Growth Rate from Consumption End

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Other Applications (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Skin Cancer (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Ovary Cancer (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Market Size and Growth Rate of Brain Tumor (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Production Volume by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Production Volume Share by Region (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Volume Share by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Production Value by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Production Value Share by Region (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Production Value Share by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Sales Volume by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Sales Volume Share by Region (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Volume Share by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Sales Value by Region (2018-2023)

    • Table China Anti-body Drug Conjugates (ADC) Sales Value Share by Region (2018-2023)

    • Figure China Anti-body Drug Conjugates (ADC) Sales Value Share by Region (2018-2023)

    • Table North China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table North China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure North China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table North China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table North China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure North China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table Central China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table Central China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure Central China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table Central China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table Central China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure Central China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table South China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table South China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure South China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table South China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table South China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure South China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table East China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table East China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure East China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table East China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table East China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure East China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table Northeast China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table Northeast China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table Northeast China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table Southwest China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table Southwest China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table Southwest China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Anti-body Drug Conjugates (ADC) Production Volume by Type (2018-2023)

    • Table Northwest China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Anti-body Drug Conjugates (ADC) Production Volume Share by Type (2018-2023)

    • Table Northwest China Anti-body Drug Conjugates (ADC) Sales Volume by Application (2018-2023)

    • Table Northwest China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Anti-body Drug Conjugates (ADC) Sales Volume Share by Application (2018-2023)

    • Table Takeda Pharmaceutical Company Limited Company Profile

    • Table Takeda Pharmaceutical Company Limited Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc Company Profile

    • Table Pfizer, Inc Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table Seagen, Inc Company Profile

    • Table Seagen, Inc Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma, Inc Company Profile

    • Table Astellas Pharma, Inc Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table ADC Therapeutics SA Company Profile

    • Table ADC Therapeutics SA Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo Company Limited Company Profile

    • Table Daiichi Sankyo Company Limited Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table Gilead Sciences, Inc Company Profile

    • Table Gilead Sciences, Inc Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Anti-body Drug Conjugates (ADC) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US